title: Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?
authors: Department of Cardiology, Rovigo General Hospital, Rovigo, Italy; Section of Internal and Cardiopulmonary Medicine, Department of Medical Science, University of Ferrara, Ferrara, Italy.
authors: Marco
authors: M
authors: Zuin
authors: Department of Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy.
authors: Gianluca
authors: G
authors: Rigatelli
authors: Department of Gastroenterology, Rovigo General Hospital, Rovigo, Italy.
authors: Giuseppe
authors: G
authors: Del Favero
authors: Department of Cardiology, Rovigo General Hospital, Rovigo, Italy.
authors: Claudio
authors: C
authors: Picariello
authors: Department of Gastroenterology, Rovigo General Hospital, Rovigo, Italy.
authors: Tamara
authors: T
authors: Meggiato
authors: Department of Cardiology, Rovigo General Hospital, Rovigo, Italy.
authors: Luca
authors: L
authors: Conte
authors: Department of Cardiac Surgery, University of Verona, Verona, Italy.
authors: Giuseppe
authors: G
authors: Faggian
authors: Section of Internal and Cardiopulmonary Medicine, Department of Medical Science, University of Ferrara, Ferrara, Italy.
authors: Giovanni
authors: G
authors: Zuliani
authors: Department of Cardiology, Rovigo General Hospital, Rovigo, Italy. Electronic address: roncon.loris@azisanrovigo.it.
authors: Loris
authors: L
authors: Roncon
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000209:etiology / Q000517:prevention & control*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D000900:Anti-Bacterial Agents
keywords: Cardiovascular prevention; Coronary artery disease; Helicobacter pylori